Foley Hoag client Dr. Margaret Shipp and her colleagues at Dana-Farber Cancer Institute have discovered that Galectin-1, a carbohydrate-binding protein, is useful for the prognosis, diagnosis, and treatment of Hodgkin's Lymphoma.
Philip Choi,
Hathaway Russell and
DeAnn Smith, of Foley Hoag's
Intellectual Property Group handled the IP matters for the work described in the attached article in Focus Online, the newsletter of Harvard Medical, Dental and Public Health Schools.
The full article is available here:
http://focus.hms.harvard.edu/2007/091407/oncology.shtml.